Allworth Financial’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.49K | Buy |
355
+39
| +12% | +$932 | ﹤0.01% | 2969 |
|
|
2025
Q1 | $8.22K | Hold |
316
| – | – | ﹤0.01% | 2503 |
|
|
2024
Q4 | $7.1K | Buy |
316
+54
| +21% | +$1.21K | ﹤0.01% | 2590 |
|
|
2024
Q3 | $3.94K | Buy |
262
+178
| +212% | +$2.68K | ﹤0.01% | 2675 |
|
|
2024
Q2 | $1.63K | Sell |
84
-494
| -85% | -$9.57K | ﹤0.01% | 3010 |
|
|
2024
Q1 | $16.9K | Sell |
578
-4
| -0.7% | -$117 | ﹤0.01% | 1864 |
|
|
2023
Q4 | $19.6K | Buy |
582
+509
| +697% | +$17.2K | ﹤0.01% | 1660 |
|
|
2023
Q3 | $2.24K | Buy |
73
+65
| +813% | +$2K | ﹤0.01% | 2487 |
|
|
2023
Q2 | $321 | Sell |
8
-4
| -33% | -$161 | ﹤0.01% | 2999 |
|
|
2023
Q1 | $490 | Buy |
+12
| New | +$490 | ﹤0.01% | 2844 |
|
|
2017
Q1 | – | Sell |
-335
| Closed | -$11K | – | 809 |
|
|
2016
Q4 | $11K | Hold |
335
| – | – | ﹤0.01% | 391 |
|
|
2016
Q3 | $11K | Buy |
+335
| New | +$11K | ﹤0.01% | 402 |
|